Phase I trial of the histone deacetylase inhibitor, depsipeptide (FR901228, NSC 630176), in patients with refractory neoplasms

Victor Sandor, Susan Bakke, Robert W. Robey, Min H. Kang, Mikhail V. Blagosklonny, Richard L. Piekarz, William D. Figg, Antonio Tito Fojo, Susan E. Bates, Eben Tucker, Barry Goldspiel, Jonathon Bender, Rebecca Brooks, Kenneth K. Chan, Stanley P. Balcerzak

Research output: Contribution to journalArticlepeer-review

534 Scopus citations

Fingerprint

Dive into the research topics of 'Phase I trial of the histone deacetylase inhibitor, depsipeptide (FR901228, NSC 630176), in patients with refractory neoplasms'. Together they form a unique fingerprint.

Medicine & Life Sciences